{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"HBV: Control vs immune tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.","id":"MTBLS280_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS280","studyUrl":"http://integmet.org/study/MTBLS280","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"70997","direction":"up","inn_name":"","iupac_name":"3-(nonanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"MPSPNFAQQQMFLK-UHFFFAOYSA-N","pvalue":0.000290209711451,"ratio":2.8082319435031144,"synonym_name":"3-(nonanoyloxy)-4-(trimethylammonio)butanoate"},{"chebi_id":"84098","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>)-3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]-4-(trimethylammonio)butanoate","metabolite_id":"MJLXQSQYKZWZCB-DQFWFXSYSA-N","pvalue":0.000900872925535,"ratio":0.5144992790937025,"synonym_name":"Octadecadienyl-L-carnitine"}],"totalFeatures":26}